Graeme Bell is a seasoned C-suite executive with over 30 years of experience in finance and biotechnology. Currently, Graeme serves as the Group CFO at Owkin, focusing on AI-driven solutions for drug discovery. Graeme’s extensive background includes key leadership roles at Merck and successful positions at venture-backed biotech companies such as Anacor Pharmaceuticals and Tmunity Therapeutics. With a commitment to mentoring future entrepreneurs, Graeme actively supports startups through Loughborough University's incubation program. Graeme also contributes as a board member and advisor to various innovative companies in the biotechnology sector.
This person is not in the org chart
This person is not in any teams
This person is not in any offices